Impact of Underlying Disease and Preoperative Factors on Postoperative Outcomes After Laparoscopic Splenectomy: A Bicentric Retrospective Analysis.
Journal
Surgical laparoscopy, endoscopy & percutaneous techniques
ISSN: 1534-4908
Titre abrégé: Surg Laparosc Endosc Percutan Tech
Pays: United States
ID NLM: 100888751
Informations de publication
Date de publication:
01 08 2022
01 08 2022
Historique:
received:
17
10
2021
accepted:
21
03
2022
pubmed:
19
5
2022
medline:
6
8
2022
entrez:
18
5
2022
Statut:
epublish
Résumé
Although the laparoscopic approach is considered the gold standard for elective splenectomy, it is still debated whether the underlying disease affects postoperative outcomes. Given the importance of good patient selection in the early stages of the learning curve for laparoscopic splenectomy (LS), this study aimed to compare the postoperative outcomes following LS for malignant diseases and benign diseases (MDs and BDs). A retrospective review of patients who underwent LS was performed at 2 different institutions between January 2013 and September 2020. Patients were classified into 2 groups based on the underlying BDs or MDs, and the 30 days postoperative outcomes were compared. Risk factors for overall complications were determined using logistic regression analysis. LS was performed for BDs and MDs in 51 (67%) and 25 (33%) patients, respectively. The overall morbidity rate and the intraoperative and postoperative complication rates were significantly higher in the MD group ( P <0.05). In the univariate analysis, the underlying MD, age above 49.5 years, body mass index >24.9, the long axis of the spleen >16 cm, and spleen weight >600 g were significantly associated with increased postoperative morbidity. In addition to the underlying disease, preoperative conditions may also affect the complication rates after LS. These findings may be helpful in patient selection, especially in the early stages of the learning curve for minimally invasive splenectomies.
Sections du résumé
BACKGROUND
Although the laparoscopic approach is considered the gold standard for elective splenectomy, it is still debated whether the underlying disease affects postoperative outcomes. Given the importance of good patient selection in the early stages of the learning curve for laparoscopic splenectomy (LS), this study aimed to compare the postoperative outcomes following LS for malignant diseases and benign diseases (MDs and BDs).
MATERIALS AND METHODS
A retrospective review of patients who underwent LS was performed at 2 different institutions between January 2013 and September 2020. Patients were classified into 2 groups based on the underlying BDs or MDs, and the 30 days postoperative outcomes were compared. Risk factors for overall complications were determined using logistic regression analysis.
RESULTS
LS was performed for BDs and MDs in 51 (67%) and 25 (33%) patients, respectively. The overall morbidity rate and the intraoperative and postoperative complication rates were significantly higher in the MD group ( P <0.05). In the univariate analysis, the underlying MD, age above 49.5 years, body mass index >24.9, the long axis of the spleen >16 cm, and spleen weight >600 g were significantly associated with increased postoperative morbidity.
CONCLUSION
In addition to the underlying disease, preoperative conditions may also affect the complication rates after LS. These findings may be helpful in patient selection, especially in the early stages of the learning curve for minimally invasive splenectomies.
Identifiants
pubmed: 35583513
doi: 10.1097/SLE.0000000000001061
pii: 00129689-202208000-00011
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
472-475Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Delaitre B, Maignien B. Splenectomy by the laparoscopic approach. Report of a case. Presse Med. 1991;20:2263.
Habermalz B, Sauerland S, Decker G, et al. Laparoscopic splene ctomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2008;22:821–848.
Casaccia M, Torelli P, Pasa A, et al. IRLSS Centers. Putative predictive parameters for the outcome of laparoscopic splenectomy: a multicenter analysis performed on the Italian Registry of Laparoscopic Surgery of the Spleen. Ann Surg. 2010;251:287–291.
Corcione F, Pirozzi F, Aragiusto G, et al. Laparoscopic splenectomy: experience of a single center in a series of 300 cases. Surg Endosc. 2012;26:2870–2876.
Bagrodia N, Button AM, Spanheimer PM, et al. Morbidity and mortality following elective splenectomy for benign and malignant hematologic conditions: analysis of the American College of Surgeons National Surgical Quality Improvement Program data. JAMA Surg. 2014;149:1022–1029.
Rodriguez-Otero Luppi C, Targarona Soler EM, Balague Ponz C, et al. Clinical, Anatomical, and Pathological Grading Score to predict technical difficulty in laparoscopic splenectomy for non-traumatic diseases. World J Surg. 2017;41:439–448.
Cadiere B, Grilli A, Bron D. Comparison of laparoscopic splenectomy outcomes for benign and malignant hemopathies. J Laparoendosc Adv Surg Tech A. 2020;30:1172–1176.
Vandenbroucke JP, von Elm E, Altman DG, et al. STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4:e297.
Corcione F, Esposito C, Cuccurullo D, et al. Technical standardization of laparoscopic splenectomy: experience with 105 cases. Surg Endosc. 2002;16:972–974.
GlobalSurg Collaborative and National Institute for Health Research Global Health Research Unit on Global Surgery. Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries. Lancet. 2021;397:387–397.
Decker G, Millat B, Guillon F, et al. Laparoscopic splenectomy for benign and malignant hematologic diseases: 35 consecutive cases. World J Surg. 1998;22:62–68.
Delaitre B, Blezel E, Samama G, et al. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Surg Laparosc Endosc Percutan Tech. 2002;12:412–419.
Rodríguez-Luna MR, Balagué C, Fernández-Ananín S, et al. Outcomes of laparoscopic splenectomy for treatment of splenomegaly: a systematic review and meta-analysis. World J Surg. 2020;45:465–479.
Casaccia M, Sormani MP, Palombo D, et al. Laparoscopic splenectomy versus open splenectomy in massive and giant spleens: should we update the 2008 EAES Guidelines? Surg Laparosc Endosc Percutan Tech. 2019;29:178–181.
Santarelli M, Lo Secco G, Celi D, et al. Are there any limits for laparoscopy in splenomegaly? Our experience. Updates Surg. 2021;73:1937–1944.
Liu P, Li Y, Ding HF, et al. A novel preoperative scoring system to predict technical difficulty in laparoscopic splenectomy for non-traumatic diseases. Surg Endosc. 2020;34:5360–5367.